

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.11875483 |
| 2 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.03694288 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.85350614 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.85350614 |
| 5 | * regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.80764506 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.72694944 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.67403712 |
| 8 | NIK/NF-kappaB signaling (GO:0038061) | 4.60203073 |
| 9 | positive thymic T cell selection (GO:0045059) | 4.58800333 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.57947977 |
| 11 | * regulation of vitamin D biosynthetic process (GO:0060556) | 4.41372909 |
| 12 | myeloid dendritic cell differentiation (GO:0043011) | 4.21325113 |
| 13 | negative thymic T cell selection (GO:0045060) | 4.20662763 |
| 14 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.16779938 |
| 15 | negative T cell selection (GO:0043383) | 4.09667147 |
| 16 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.06798888 |
| 17 | myeloid dendritic cell activation (GO:0001773) | 3.97118936 |
| 18 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.90630758 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.88581403 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.87491779 |
| 21 | negative regulation of cell killing (GO:0031342) | 3.87491779 |
| 22 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.86771002 |
| 23 | positive regulation of isotype switching (GO:0045830) | 3.86514782 |
| 24 | response to muramyl dipeptide (GO:0032495) | 3.86191524 |
| 25 | leukocyte aggregation (GO:0070486) | 3.84688561 |
| 26 | defense response to protozoan (GO:0042832) | 3.82491232 |
| 27 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.79148340 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 3.73866308 |
| 29 | regulation of fever generation (GO:0031620) | 3.73094699 |
| 30 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.72662774 |
| 31 | response to protozoan (GO:0001562) | 3.72241903 |
| 32 | positive regulation of interleukin-2 production (GO:0032743) | 3.71941730 |
| 33 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.71206990 |
| 34 | positive regulation by symbiont of host defense response (GO:0052509) | 3.69641065 |
| 35 | modulation by symbiont of host defense response (GO:0052031) | 3.69641065 |
| 36 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.69641065 |
| 37 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.69641065 |
| 38 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.69641065 |
| 39 | modulation by symbiont of host immune response (GO:0052553) | 3.69641065 |
| 40 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.66134112 |
| 41 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.61717591 |
| 42 | regulation of podosome assembly (GO:0071801) | 3.61717373 |
| 43 | tolerance induction (GO:0002507) | 3.61366725 |
| 44 | positive regulation of B cell differentiation (GO:0045579) | 3.59309817 |
| 45 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.59095197 |
| 46 | positive T cell selection (GO:0043368) | 3.57037317 |
| 47 | positive regulation of humoral immune response (GO:0002922) | 3.56759364 |
| 48 | regulation of chemokine biosynthetic process (GO:0045073) | 3.55739906 |
| 49 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.53548218 |
| 50 | positive regulation of B cell mediated immunity (GO:0002714) | 3.53548218 |
| 51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.52155744 |
| 52 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.51000961 |
| 53 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.48796975 |
| 54 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.48023967 |
| 55 | thymic T cell selection (GO:0045061) | 3.47210674 |
| 56 | T-helper 1 type immune response (GO:0042088) | 3.46311636 |
| 57 | * regulation of vitamin metabolic process (GO:0030656) | 3.44000025 |
| 58 | regulation of immunoglobulin secretion (GO:0051023) | 3.43260094 |
| 59 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.43151485 |
| 60 | response to interleukin-15 (GO:0070672) | 3.38036992 |
| 61 | response to type I interferon (GO:0034340) | 3.36538719 |
| 62 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.33827675 |
| 63 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.33448453 |
| 64 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.32553702 |
| 65 | cellular response to type I interferon (GO:0071357) | 3.31137203 |
| 66 | type I interferon signaling pathway (GO:0060337) | 3.31137203 |
| 67 | positive regulation of type 2 immune response (GO:0002830) | 3.29895317 |
| 68 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.29538351 |
| 69 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.28929579 |
| 70 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.26793128 |
| 71 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.26466195 |
| 72 | positive regulation of DNA recombination (GO:0045911) | 3.26073230 |
| 73 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.25557805 |
| 74 | regulation of B cell differentiation (GO:0045577) | 3.22690252 |
| 75 | regulation of regulatory T cell differentiation (GO:0045589) | 3.22539299 |
| 76 | T cell migration (GO:0072678) | 3.22038957 |
| 77 | T cell selection (GO:0045058) | 3.20127211 |
| 78 | regulation of interferon-alpha production (GO:0032647) | 3.17390100 |
| 79 | positive regulation of interleukin-12 production (GO:0032735) | 3.16172876 |
| 80 | positive regulation of interferon-alpha production (GO:0032727) | 3.14773537 |
| 81 | positive regulation of interleukin-17 production (GO:0032740) | 3.13436489 |
| 82 | interferon-gamma production (GO:0032609) | 3.12328712 |
| 83 | response to peptidoglycan (GO:0032494) | 3.11757564 |
| 84 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.11464823 |
| 85 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.06996632 |
| 86 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.06891217 |
| 87 | germinal center formation (GO:0002467) | 3.03558767 |
| 88 | dendritic cell differentiation (GO:0097028) | 3.02419541 |
| 89 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.01388761 |
| 90 | immunoglobulin mediated immune response (GO:0016064) | 3.01225276 |
| 91 | regulation of T cell tolerance induction (GO:0002664) | 3.01201061 |
| 92 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.98733011 |
| 93 | mature B cell differentiation (GO:0002335) | 2.97591646 |
| 94 | T cell lineage commitment (GO:0002360) | 2.96555059 |
| 95 | * regulation of interleukin-12 production (GO:0032655) | 2.93942477 |
| 96 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.93780032 |
| 97 | regulation of chronic inflammatory response (GO:0002676) | 2.92866921 |
| 98 | positive regulation of T cell cytokine production (GO:0002726) | 2.92753738 |
| 99 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.91227212 |
| 100 | positive regulation of immunoglobulin production (GO:0002639) | 2.89893883 |
| 101 | detection of other organism (GO:0098543) | 2.89201403 |
| 102 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.89144686 |
| 103 | regulation of interleukin-2 production (GO:0032663) | 2.87972217 |
| 104 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.87909061 |
| 105 | regulation of B cell mediated immunity (GO:0002712) | 2.87627282 |
| 106 | natural killer cell differentiation (GO:0001779) | 2.87344040 |
| 107 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.87321299 |
| 108 | regulation of T-helper cell differentiation (GO:0045622) | 2.86654035 |
| 109 | regulation of isotype switching (GO:0045191) | 2.86186146 |
| 110 | * negative regulation of interleukin-12 production (GO:0032695) | 2.83160252 |
| 111 | cellular response to interleukin-15 (GO:0071350) | 2.83052945 |
| 112 | positive regulation of defense response to virus by host (GO:0002230) | 2.82448859 |
| 113 | neutrophil activation involved in immune response (GO:0002283) | 2.82438250 |
| 114 | regulation of antigen processing and presentation (GO:0002577) | 2.81222919 |
| 115 | positive regulation of interleukin-10 production (GO:0032733) | 2.80947611 |
| 116 | regulation of type 2 immune response (GO:0002828) | 2.80880641 |
| 117 | T cell homeostasis (GO:0043029) | 2.80021897 |
| 118 | positive regulation of interferon-beta production (GO:0032728) | 2.79512778 |
| 119 | regulation of tolerance induction (GO:0002643) | 2.78106060 |
| 120 | cellular response to interferon-gamma (GO:0071346) | 2.77627093 |
| 121 | natural killer cell activation (GO:0030101) | 2.77110450 |
| 122 | T cell proliferation (GO:0042098) | 2.75811351 |
| 123 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.75779274 |
| 124 | T-helper cell differentiation (GO:0042093) | 2.74977318 |
| 125 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.74977318 |
| 126 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.73846027 |
| 127 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.73412950 |
| 128 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.73068153 |
| 129 | B cell mediated immunity (GO:0019724) | 2.72962515 |
| 130 | regulation of heat generation (GO:0031650) | 2.72625216 |
| 131 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.72472716 |
| 132 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.72341519 |
| 133 | positive regulation of heat generation (GO:0031652) | 2.71879754 |
| 134 | modulation by symbiont of host cellular process (GO:0044068) | 2.71810949 |
| 135 | positive regulation of acute inflammatory response (GO:0002675) | 2.71737634 |
| 136 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.70475666 |
| 137 | leukocyte cell-cell adhesion (GO:0007159) | 2.70063643 |
| 138 | positive regulation of B cell activation (GO:0050871) | 2.69268224 |
| 139 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.68953339 |
| 140 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.68517705 |
| 141 | growth hormone receptor signaling pathway (GO:0060396) | 2.67143889 |
| 142 | negative regulation of T cell mediated immunity (GO:0002710) | 2.66252887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.77041873 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.93443846 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.91915267 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.80286349 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.74206975 |
| 6 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.61968197 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.60269641 |
| 8 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.38967690 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.37410178 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.33530854 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.28424584 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.11225075 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 3.06469553 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.99811151 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.91944225 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.89832252 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.77336641 |
| 18 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.71495630 |
| 19 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.68569587 |
| 20 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.59323577 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.55960845 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.47377812 |
| 23 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.47149501 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.44080700 |
| 25 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.43126253 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.33595352 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 2.22651169 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.19707290 |
| 29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.14080696 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.07570664 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.04524850 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.99558459 |
| 33 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.93511181 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.93260852 |
| 35 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.93129072 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84219202 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.80567934 |
| 38 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.79596166 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76789402 |
| 40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.71709091 |
| 41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.59793734 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.59483355 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.57873025 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.57774653 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57020850 |
| 46 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.53758802 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.53505573 |
| 48 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.44777660 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.43681285 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38789762 |
| 51 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35001150 |
| 52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34559241 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30652939 |
| 54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30537728 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29248266 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26829088 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25763718 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24705574 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23363711 |
| 60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21815952 |
| 61 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21776731 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21520627 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19028389 |
| 64 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.10663679 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10191399 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08409899 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01205192 |
| 68 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00499799 |
| 69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00124646 |
| 70 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99724881 |
| 71 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99283504 |
| 72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96381732 |
| 73 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96072680 |
| 74 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92892164 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91954325 |
| 76 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91464485 |
| 77 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.91263291 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.91226895 |
| 79 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91193959 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.89059625 |
| 81 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88651258 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88086575 |
| 83 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87337938 |
| 84 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85651440 |
| 85 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85407938 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83729679 |
| 87 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.83394351 |
| 88 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.82241745 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81308527 |
| 90 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80701325 |
| 91 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.79801985 |
| 92 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.79682177 |
| 93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79645832 |
| 94 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.79377930 |
| 95 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.79377930 |
| 96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79377524 |
| 97 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.79291701 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.78955594 |
| 99 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.78761250 |
| 100 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78558475 |
| 101 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.78071965 |
| 102 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77696038 |
| 103 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.77281544 |
| 104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76348094 |
| 105 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.75879233 |
| 106 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.75408365 |
| 107 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74922963 |
| 108 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.74586993 |
| 109 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74525608 |
| 110 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74141629 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74029439 |
| 112 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73712938 |
| 113 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.72210247 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.99567894 |
| 2 | MP0003436_decreased_susceptibility_to | 3.63409213 |
| 3 | MP0000685_abnormal_immune_system | 3.46035535 |
| 4 | MP0003300_gastrointestinal_ulcer | 3.25232387 |
| 5 | MP0005671_abnormal_response_to | 3.21409929 |
| 6 | * MP0005387_immune_system_phenotype | 3.09868727 |
| 7 | * MP0001790_abnormal_immune_system | 3.09868727 |
| 8 | MP0003763_abnormal_thymus_physiology | 3.07509260 |
| 9 | * MP0001800_abnormal_humoral_immune | 2.97597686 |
| 10 | * MP0005000_abnormal_immune_tolerance | 2.93754638 |
| 11 | * MP0009785_altered_susceptibility_to | 2.88287844 |
| 12 | MP0004510_myositis | 2.69287525 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.64540363 |
| 14 | * MP0002723_abnormal_immune_serum | 2.64240179 |
| 15 | * MP0005025_abnormal_response_to | 2.60606556 |
| 16 | MP0003724_increased_susceptibility_to | 2.60185618 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.57538022 |
| 18 | MP0001853_heart_inflammation | 2.46705984 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.41936546 |
| 20 | * MP0002420_abnormal_adaptive_immunity | 2.40974687 |
| 21 | * MP0001819_abnormal_immune_cell | 2.40613418 |
| 22 | * MP0003303_peritoneal_inflammation | 2.35118629 |
| 23 | * MP0002419_abnormal_innate_immunity | 2.32991242 |
| 24 | * MP0002405_respiratory_system_inflammati | 2.29794806 |
| 25 | * MP0002398_abnormal_bone_marrow | 2.22762545 |
| 26 | MP0002396_abnormal_hematopoietic_system | 2.22478084 |
| 27 | MP0002006_tumorigenesis | 2.20602244 |
| 28 | MP0006082_CNS_inflammation | 2.07656062 |
| 29 | MP0005451_abnormal_body_composition | 2.05292289 |
| 30 | * MP0010155_abnormal_intestine_physiology | 2.03488108 |
| 31 | * MP0000716_abnormal_immune_system | 2.01733131 |
| 32 | MP0001873_stomach_inflammation | 1.99290613 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.99130259 |
| 34 | MP0004947_skin_inflammation | 1.94625389 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.81407271 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.81293539 |
| 37 | * MP0000689_abnormal_spleen_morphology | 1.77936590 |
| 38 | * MP0001845_abnormal_inflammatory_respons | 1.76663976 |
| 39 | MP0009840_abnormal_foam_cell | 1.73848196 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.73776046 |
| 41 | * MP0002722_abnormal_immune_system | 1.72850503 |
| 42 | * MP0002429_abnormal_blood_cell | 1.67215572 |
| 43 | MP0008004_abnormal_stomach_pH | 1.61332275 |
| 44 | * MP0000703_abnormal_thymus_morphology | 1.57116934 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.57115614 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.57115614 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.55855510 |
| 48 | * MP0003866_abnormal_defecation | 1.53655839 |
| 49 | MP0002933_joint_inflammation | 1.50104596 |
| 50 | MP0009278_abnormal_bone_marrow | 1.48342552 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.48283973 |
| 52 | MP0002139_abnormal_hepatobiliary_system | 1.40435065 |
| 53 | MP0010352_gastrointestinal_tract_polyps | 1.38970574 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.33779001 |
| 55 | MP0003448_altered_tumor_morphology | 1.33568556 |
| 56 | MP0002332_abnormal_exercise_endurance | 1.31285716 |
| 57 | MP0005310_abnormal_salivary_gland | 1.29014965 |
| 58 | MP0008057_abnormal_DNA_replication | 1.28016288 |
| 59 | MP0000490_abnormal_crypts_of | 1.26780215 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.26343856 |
| 61 | MP0000858_altered_metastatic_potential | 1.23324790 |
| 62 | * MP0008469_abnormal_protein_level | 1.23156356 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.19164828 |
| 64 | MP0009764_decreased_sensitivity_to | 1.17444997 |
| 65 | MP0002877_abnormal_melanocyte_morpholog | 1.03016450 |
| 66 | MP0005164_abnormal_response_to | 0.99960724 |
| 67 | MP0006054_spinal_hemorrhage | 0.99913344 |
| 68 | MP0002254_reproductive_system_inflammat | 0.99166864 |
| 69 | MP0010307_abnormal_tumor_latency | 0.97876086 |
| 70 | MP0001851_eye_inflammation | 0.97552039 |
| 71 | MP0000343_altered_response_to | 0.92876505 |
| 72 | MP0003195_calcinosis | 0.92039665 |
| 73 | MP0003566_abnormal_cell_adhesion | 0.90706840 |
| 74 | MP0003045_fibrosis | 0.88843725 |
| 75 | MP0008260_abnormal_autophagy | 0.87692257 |
| 76 | MP0005390_skeleton_phenotype | 0.87309024 |
| 77 | MP0002019_abnormal_tumor_incidence | 0.87079129 |
| 78 | MP0003690_abnormal_glial_cell | 0.86874768 |
| 79 | MP0003828_pulmonary_edema | 0.86131903 |
| 80 | MP0003091_abnormal_cell_migration | 0.85037989 |
| 81 | MP0000604_amyloidosis | 0.84746033 |
| 82 | MP0009763_increased_sensitivity_to | 0.84421167 |
| 83 | MP0003453_abnormal_keratinocyte_physiol | 0.84108530 |
| 84 | MP0005058_abnormal_lysosome_morphology | 0.83894739 |
| 85 | MP0005023_abnormal_wound_healing | 0.83370886 |
| 86 | MP0000371_diluted_coat_color | 0.76880853 |
| 87 | MP0003172_abnormal_lysosome_physiology | 0.75306171 |
| 88 | MP0005165_increased_susceptibility_to | 0.75247535 |
| 89 | * MP0003795_abnormal_bone_structure | 0.74540478 |
| 90 | MP0003075_altered_response_to | 0.74508289 |
| 91 | MP0003806_abnormal_nucleotide_metabolis | 0.73153650 |
| 92 | MP0001881_abnormal_mammary_gland | 0.71573621 |
| 93 | MP0000249_abnormal_blood_vessel | 0.70013285 |
| 94 | MP0008961_abnormal_basal_metabolism | 0.69473520 |
| 95 | MP0005166_decreased_susceptibility_to | 0.67080082 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.66347829 |
| 97 | MP0000733_abnormal_muscle_development | 0.61249744 |
| 98 | MP0000767_abnormal_smooth_muscle | 0.61101865 |
| 99 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60806342 |
| 100 | MP0004883_abnormal_blood_vessel | 0.60645686 |
| 101 | MP0005174_abnormal_tail_pigmentation | 0.60298237 |
| 102 | MP0008874_decreased_physiological_sensi | 0.58722913 |
| 103 | MP0001348_abnormal_lacrimal_gland | 0.58500270 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.54776799 |
| 105 | MP0003191_abnormal_cellular_cholesterol | 0.54527571 |
| 106 | MP0003943_abnormal_hepatobiliary_system | 0.54135534 |
| 107 | MP0008007_abnormal_cellular_replicative | 0.53648413 |
| 108 | MP0005535_abnormal_body_temperature | 0.53221057 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.52769903 |
| 110 | * MP0000609_abnormal_liver_physiology | 0.52652830 |
| 111 | MP0000627_abnormal_mammary_gland | 0.52476799 |
| 112 | * MP0001663_abnormal_digestive_system | 0.52238993 |
| 113 | MP0000569_abnormal_digit_pigmentation | 0.52194193 |
| 114 | MP0001243_abnormal_dermal_layer | 0.52098607 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.50652897 |
| 116 | MP0001191_abnormal_skin_condition | 0.49878598 |
| 117 | * MP0001216_abnormal_epidermal_layer | 0.49745180 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.49394644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.82478970 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.02572954 |
| 3 | Stomatitis (HP:0010280) | 4.90467387 |
| 4 | Recurrent fungal infections (HP:0002841) | 4.48152762 |
| 5 | Myositis (HP:0100614) | 4.38511070 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.25499510 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.25499510 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.25499510 |
| 9 | Recurrent viral infections (HP:0004429) | 4.17245735 |
| 10 | Recurrent abscess formation (HP:0002722) | 4.14827944 |
| 11 | Gastrointestinal infarctions (HP:0005244) | 4.13082206 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.06881426 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 4.02826759 |
| 14 | Optic neuritis (HP:0100653) | 4.02826759 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 3.99999100 |
| 16 | Orchitis (HP:0100796) | 3.93521377 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 3.81402407 |
| 18 | T lymphocytopenia (HP:0005403) | 3.70722639 |
| 19 | Abnormality of T cell number (HP:0011839) | 3.68371711 |
| 20 | Thrombocytosis (HP:0001894) | 3.68354478 |
| 21 | Arterial thrombosis (HP:0004420) | 3.66814012 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.63563642 |
| 23 | Vasculitis (HP:0002633) | 3.59490782 |
| 24 | Increased density of long bones (HP:0006392) | 3.55829051 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.53146568 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.53146568 |
| 27 | Pulmonary infiltrates (HP:0002113) | 3.44357841 |
| 28 | Abnormality of T cells (HP:0002843) | 3.42757111 |
| 29 | Chronic otitis media (HP:0000389) | 3.29552989 |
| 30 | Abnormality of T cell physiology (HP:0011840) | 3.13852267 |
| 31 | Recurrent bronchitis (HP:0002837) | 3.12963357 |
| 32 | Recurrent skin infections (HP:0001581) | 3.08914368 |
| 33 | Chest pain (HP:0100749) | 3.08799478 |
| 34 | Severe combined immunodeficiency (HP:0004430) | 3.04494213 |
| 35 | Loss of speech (HP:0002371) | 3.02831047 |
| 36 | Autoimmune thrombocytopenia (HP:0001973) | 3.01566597 |
| 37 | Meningitis (HP:0001287) | 2.99557772 |
| 38 | Autoimmune hemolytic anemia (HP:0001890) | 2.97083032 |
| 39 | Vacuolated lymphocytes (HP:0001922) | 2.92505277 |
| 40 | Inflammation of the large intestine (HP:0002037) | 2.90390712 |
| 41 | Dysostosis multiplex (HP:0000943) | 2.88535344 |
| 42 | Myocardial infarction (HP:0001658) | 2.86471703 |
| 43 | Fatigue (HP:0012378) | 2.86394311 |
| 44 | IgA deficiency (HP:0002720) | 2.83963963 |
| 45 | IgM deficiency (HP:0002850) | 2.83565258 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.83515939 |
| 47 | Gastrointestinal inflammation (HP:0004386) | 2.81600718 |
| 48 | Hemoptysis (HP:0002105) | 2.76495378 |
| 49 | Chronic obstructive pulmonary disease (HP:0006510) | 2.76091046 |
| 50 | Obstructive lung disease (HP:0006536) | 2.76091046 |
| 51 | Colitis (HP:0002583) | 2.75902385 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.74417248 |
| 53 | Combined immunodeficiency (HP:0005387) | 2.73507535 |
| 54 | Peritonitis (HP:0002586) | 2.71642893 |
| 55 | Increased cerebral lipofuscin (HP:0011813) | 2.71534567 |
| 56 | Nasal polyposis (HP:0100582) | 2.70737427 |
| 57 | Agammaglobulinemia (HP:0004432) | 2.70106803 |
| 58 | Abnormality of macrophages (HP:0004311) | 2.69514090 |
| 59 | Cellulitis (HP:0100658) | 2.69046372 |
| 60 | Leukocytosis (HP:0001974) | 2.68813942 |
| 61 | Gastrointestinal stroma tumor (HP:0100723) | 2.68449788 |
| 62 | Persistence of primary teeth (HP:0006335) | 2.66805012 |
| 63 | Pustule (HP:0200039) | 2.65890400 |
| 64 | Increased IgM level (HP:0003496) | 2.64674234 |
| 65 | Abnormality of B cell number (HP:0010975) | 2.62986588 |
| 66 | B lymphocytopenia (HP:0010976) | 2.62986588 |
| 67 | Gingivitis (HP:0000230) | 2.62177844 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.62172858 |
| 69 | Interstitial pulmonary disease (HP:0006530) | 2.61837041 |
| 70 | Periodontitis (HP:0000704) | 2.60886928 |
| 71 | Disinhibition (HP:0000734) | 2.59176899 |
| 72 | Amaurosis fugax (HP:0100576) | 2.59040638 |
| 73 | Gingival bleeding (HP:0000225) | 2.56729803 |
| 74 | Chronic diarrhea (HP:0002028) | 2.56038769 |
| 75 | Urticaria (HP:0001025) | 2.50520130 |
| 76 | Spontaneous hematomas (HP:0007420) | 2.49876195 |
| 77 | Polyneuropathy (HP:0001271) | 2.48706857 |
| 78 | Abnormality of the nasal mucosa (HP:0000433) | 2.45737272 |
| 79 | Lymphopenia (HP:0001888) | 2.45564689 |
| 80 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.44614654 |
| 81 | Keratoconjunctivitis (HP:0001096) | 2.42737316 |
| 82 | Anorexia (HP:0002039) | 2.42700655 |
| 83 | IgG deficiency (HP:0004315) | 2.39453112 |
| 84 | Acute myeloid leukemia (HP:0004808) | 2.39013928 |
| 85 | Abnormality of the fingertips (HP:0001211) | 2.38239624 |
| 86 | Increased IgE level (HP:0003212) | 2.37648874 |
| 87 | Osteomyelitis (HP:0002754) | 2.35973866 |
| 88 | Basal ganglia calcification (HP:0002135) | 2.25179418 |
| 89 | Emphysema (HP:0002097) | 2.24798062 |
| 90 | Encephalitis (HP:0002383) | 2.23662842 |
| 91 | Epistaxis (HP:0000421) | 2.23498724 |
| 92 | Increased serum ferritin (HP:0003281) | 2.21720100 |
| 93 | Osteolytic defects of the hand bones (HP:0009699) | 2.19905364 |
| 94 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.19905364 |
| 95 | Hypergammaglobulinemia (HP:0010702) | 2.18950948 |
| 96 | Glomerulopathy (HP:0100820) | 2.18818193 |
| 97 | Amyloidosis (HP:0011034) | 2.17919809 |
| 98 | Abnormality of the prostate (HP:0008775) | 2.16859466 |
| 99 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.13353033 |
| 100 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.13353033 |
| 101 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.13353033 |
| 102 | Lymphoma (HP:0002665) | 2.12331412 |
| 103 | Granulocytopenia (HP:0001913) | 2.12009931 |
| 104 | Eosinophilia (HP:0001880) | 2.11294146 |
| 105 | Abnormality of the peritoneum (HP:0002585) | 2.10869953 |
| 106 | Vertigo (HP:0002321) | 2.10470073 |
| 107 | Joint swelling (HP:0001386) | 2.10450324 |
| 108 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.09684124 |
| 109 | Keratitis (HP:0000491) | 2.09637303 |
| 110 | Abnormality of the endocardium (HP:0004306) | 2.09411839 |
| 111 | Abnormality of the pericardium (HP:0001697) | 2.08396965 |
| 112 | Arthralgia (HP:0002829) | 2.05526512 |
| 113 | Hematochezia (HP:0002573) | 2.05379176 |
| 114 | Mucopolysacchariduria (HP:0008155) | 2.04536333 |
| 115 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04536333 |
| 116 | Skin ulcer (HP:0200042) | 2.03434219 |
| 117 | Restrictive lung disease (HP:0002091) | 2.01415602 |
| 118 | Pulmonary embolism (HP:0002204) | 2.00673240 |
| 119 | Premature loss of primary teeth (HP:0006323) | 1.98833436 |
| 120 | Frequent falls (HP:0002359) | 1.95509559 |
| 121 | Petechiae (HP:0000967) | 1.94939836 |
| 122 | Polycythemia (HP:0001901) | 1.94828601 |
| 123 | Thyroiditis (HP:0100646) | 1.94725598 |
| 124 | Thrombophlebitis (HP:0004418) | 1.92412763 |
| 125 | Acne (HP:0001061) | 1.91873119 |
| 126 | Abnormality of eosinophils (HP:0001879) | 1.91586295 |
| 127 | Abnormality of the pleura (HP:0002103) | 1.90327734 |
| 128 | Gangrene (HP:0100758) | 1.90025318 |
| 129 | Episodic fever (HP:0001954) | 1.89711430 |
| 130 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89372653 |
| 131 | Purpura (HP:0000979) | 1.87753599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.55418718 |
| 2 | MAP3K14 | 4.02984677 |
| 3 | TXK | 3.94774782 |
| 4 | JAK3 | 3.50987732 |
| 5 | PRPF4B | 3.02413839 |
| 6 | ZAP70 | 2.94887825 |
| 7 | TBK1 | 2.60592086 |
| 8 | TYK2 | 2.55072283 |
| 9 | IKBKE | 2.27323389 |
| 10 | MATK | 2.23552346 |
| 11 | MAP2K3 | 2.22475685 |
| 12 | EEF2K | 2.20713823 |
| 13 | IRAK3 | 2.13972652 |
| 14 | * IKBKB | 2.07971924 |
| 15 | BMPR2 | 2.02339885 |
| 16 | PIM2 | 1.96011055 |
| 17 | DDR2 | 1.85359364 |
| 18 | GRK7 | 1.84425875 |
| 19 | RPS6KA4 | 1.83585893 |
| 20 | IRAK4 | 1.79161207 |
| 21 | JAK1 | 1.77690239 |
| 22 | * CHUK | 1.70430570 |
| 23 | BLK | 1.70429516 |
| 24 | RIPK4 | 1.68291647 |
| 25 | TEC | 1.65345496 |
| 26 | BTK | 1.64089292 |
| 27 | KIT | 1.58881989 |
| 28 | ITK | 1.58051567 |
| 29 | CSK | 1.55104866 |
| 30 | FGR | 1.53167756 |
| 31 | MAP3K10 | 1.50222690 |
| 32 | MAP3K11 | 1.48798335 |
| 33 | FGFR4 | 1.46737948 |
| 34 | RIPK1 | 1.44139971 |
| 35 | TRIB3 | 1.43701247 |
| 36 | CDK12 | 1.43312948 |
| 37 | STK10 | 1.43040453 |
| 38 | MAP3K3 | 1.41812425 |
| 39 | ERN1 | 1.40422822 |
| 40 | TAOK1 | 1.37686801 |
| 41 | EPHB1 | 1.36087431 |
| 42 | LCK | 1.34306164 |
| 43 | SYK | 1.34070549 |
| 44 | HCK | 1.30255257 |
| 45 | PIM1 | 1.29760350 |
| 46 | CDC42BPA | 1.24224628 |
| 47 | MAP3K13 | 1.22604580 |
| 48 | FGFR3 | 1.19070471 |
| 49 | NLK | 1.16761481 |
| 50 | IRAK2 | 1.12804641 |
| 51 | TAOK2 | 1.09937626 |
| 52 | MOS | 1.09845269 |
| 53 | TGFBR2 | 1.09344079 |
| 54 | JAK2 | 1.06639645 |
| 55 | PKN2 | 0.99056545 |
| 56 | EPHA3 | 0.96912784 |
| 57 | TAOK3 | 0.96737083 |
| 58 | CSF1R | 0.95650360 |
| 59 | LRRK2 | 0.95000772 |
| 60 | LYN | 0.93777925 |
| 61 | SMG1 | 0.87440446 |
| 62 | MAP3K7 | 0.86270804 |
| 63 | FES | 0.84359435 |
| 64 | NME2 | 0.83783546 |
| 65 | PTK6 | 0.83721567 |
| 66 | MAP3K5 | 0.78995911 |
| 67 | TRPM7 | 0.75142616 |
| 68 | TSSK6 | 0.71899134 |
| 69 | TTN | 0.70830309 |
| 70 | MST4 | 0.70041637 |
| 71 | GRK6 | 0.68267967 |
| 72 | TYRO3 | 0.67829562 |
| 73 | ALK | 0.67120901 |
| 74 | SIK1 | 0.66859743 |
| 75 | TGFBR1 | 0.64495304 |
| 76 | FLT3 | 0.64405509 |
| 77 | MARK3 | 0.62993584 |
| 78 | NEK9 | 0.61198880 |
| 79 | CLK1 | 0.58824004 |
| 80 | SIK2 | 0.58615014 |
| 81 | PRKCQ | 0.58454549 |
| 82 | MAPK11 | 0.58021307 |
| 83 | MAPKAPK2 | 0.57096083 |
| 84 | RAF1 | 0.56556018 |
| 85 | CDK4 | 0.55188395 |
| 86 | MAP3K8 | 0.54039072 |
| 87 | CDK6 | 0.53939170 |
| 88 | MAP3K1 | 0.53818017 |
| 89 | SIK3 | 0.51975767 |
| 90 | PDGFRB | 0.51534506 |
| 91 | IRAK1 | 0.51353152 |
| 92 | ARAF | 0.49095718 |
| 93 | PASK | 0.48041658 |
| 94 | PDGFRA | 0.48023689 |
| 95 | EGFR | 0.46543632 |
| 96 | ABL1 | 0.46520700 |
| 97 | PDK1 | 0.45914849 |
| 98 | DMPK | 0.45905102 |
| 99 | STK4 | 0.45881514 |
| 100 | BMX | 0.44739128 |
| 101 | RPS6KA1 | 0.42748656 |
| 102 | BRD4 | 0.41715472 |
| 103 | RPS6KA5 | 0.40991978 |
| 104 | HIPK2 | 0.40967607 |
| 105 | STK24 | 0.39635911 |
| 106 | PRKCH | 0.39346177 |
| 107 | ICK | 0.39263345 |
| 108 | MAPK7 | 0.37231115 |
| 109 | STK3 | 0.36889523 |
| 110 | CDK9 | 0.35698078 |
| 111 | KSR2 | 0.34100244 |
| 112 | PAK2 | 0.33975490 |
| 113 | MELK | 0.33804729 |
| 114 | PDPK1 | 0.32995542 |
| 115 | NUAK1 | 0.32293435 |
| 116 | MAPK4 | 0.32142731 |
| 117 | ADRBK2 | 0.30215278 |
| 118 | RPS6KL1 | 0.29297766 |
| 119 | RPS6KC1 | 0.29297766 |
| 120 | MTOR | 0.28964031 |
| 121 | INSR | 0.28397104 |
| 122 | KDR | 0.28380104 |
| 123 | RPS6KA6 | 0.27709032 |
| 124 | GSK3A | 0.26793893 |
| 125 | IGF1R | 0.25167099 |
| 126 | MARK2 | 0.25081891 |
| 127 | MAP2K6 | 0.24954323 |
| 128 | TESK2 | 0.22188350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.15033722 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.11044769 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.99004121 |
| 4 | * Leishmaniasis_Homo sapiens_hsa05140 | 2.89316777 |
| 5 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.70008638 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.61373560 |
| 7 | * Measles_Homo sapiens_hsa05162 | 2.53838205 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.45826612 |
| 9 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.34943796 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.32291893 |
| 11 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.16638624 |
| 12 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.08403626 |
| 13 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.02710847 |
| 14 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.98120003 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.93425232 |
| 16 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.92172748 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.91894046 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.90479111 |
| 19 | * Legionellosis_Homo sapiens_hsa05134 | 1.88730401 |
| 20 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.88472773 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.88212445 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.86884394 |
| 23 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.81589857 |
| 24 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.78426565 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.74693556 |
| 26 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.71261957 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.68219450 |
| 28 | * Influenza A_Homo sapiens_hsa05164 | 1.67000889 |
| 29 | * Tuberculosis_Homo sapiens_hsa05152 | 1.50280517 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.49187885 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46808881 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45306748 |
| 33 | * Pertussis_Homo sapiens_hsa05133 | 1.44331622 |
| 34 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.37945875 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35785777 |
| 36 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35653541 |
| 37 | * Hepatitis B_Homo sapiens_hsa05161 | 1.31129453 |
| 38 | * Apoptosis_Homo sapiens_hsa04210 | 1.30341263 |
| 39 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27447182 |
| 40 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.25508909 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21013289 |
| 42 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18917786 |
| 43 | * Shigellosis_Homo sapiens_hsa05131 | 1.10100256 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07925023 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.05674802 |
| 46 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.05357970 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 1.00103261 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98253057 |
| 49 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97681150 |
| 50 | * Salmonella infection_Homo sapiens_hsa05132 | 0.97034984 |
| 51 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.96055465 |
| 52 | * Hepatitis C_Homo sapiens_hsa05160 | 0.94516748 |
| 53 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.93973687 |
| 54 | * Small cell lung cancer_Homo sapiens_hsa05222 | 0.93496584 |
| 55 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87332259 |
| 56 | Bladder cancer_Homo sapiens_hsa05219 | 0.84989924 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81989739 |
| 58 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78984502 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 0.77686314 |
| 60 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76450635 |
| 61 | * Pancreatic cancer_Homo sapiens_hsa05212 | 0.73902588 |
| 62 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68244636 |
| 63 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63983197 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62030463 |
| 65 | * Amoebiasis_Homo sapiens_hsa05146 | 0.58205912 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57761933 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56200584 |
| 68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55558716 |
| 69 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54939547 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53457695 |
| 71 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.51048327 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49049735 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48289410 |
| 74 | * Insulin resistance_Homo sapiens_hsa04931 | 0.44909936 |
| 75 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43504501 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42916290 |
| 77 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42627642 |
| 78 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42010467 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41221440 |
| 80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39020559 |
| 81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38310516 |
| 82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38118578 |
| 83 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35759495 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.35756715 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35406256 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34799047 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.34669543 |
| 88 | Other glycan degradation_Homo sapiens_hsa00511 | 0.33953620 |
| 89 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.32104918 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.29961633 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28117601 |
| 92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.26840460 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26782405 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26692392 |
| 95 | Base excision repair_Homo sapiens_hsa03410 | 0.26341768 |
| 96 | * Prostate cancer_Homo sapiens_hsa05215 | 0.25191614 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24811686 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.24493044 |
| 99 | Focal adhesion_Homo sapiens_hsa04510 | 0.24251367 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.23820097 |
| 101 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.23698493 |
| 102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23631747 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.23252181 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21968961 |
| 105 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.21699731 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.21452723 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21354358 |
| 108 | Lysine degradation_Homo sapiens_hsa00310 | 0.20778984 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.20597691 |
| 110 | Spliceosome_Homo sapiens_hsa03040 | 0.20006632 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.19432025 |
| 112 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.19404328 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.18668535 |
| 114 | Adherens junction_Homo sapiens_hsa04520 | 0.18281577 |
| 115 | Glioma_Homo sapiens_hsa05214 | 0.12368601 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.11095476 |

